305 results
Page 4 of 16
6-K
EX-99
ygfn0ln
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
0ps dr6dhnril09d24at
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
6-K
EX-99
dqvygo2h 0atpto
4 May 21
BioLineRx Announces Positive Top-Line Results from
7:12am
6-K
EX-1
e7dfrzjciy1i3 xq
15 Apr 21
BioLineRx Announces Presentation at 2021 American
4:01pm
POS AM
f7kg2phu7 ohkp2
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
xidrbfz0vx iy6v754x
23 Feb 21
BioLineRx Reports Year-End 2020 Financial Results
7:02am
6-K
EX-99.1
bnwd ekq3q
22 Jan 21
BioLineRx Announces Closing of $34.5 Million Bought Deal Offering and Full Exercise of
4:21pm
6-K
EX-99.1
1c2u oj25189
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99.2
qrvr9mz
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
lgoq29ne7s
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
w7cu9ej
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
ylaicg4q1r85ut
21 Jan 21
Prospectus supplement for primary offering
4:31pm
FWP
cosd 6b6iuqf2i
19 Jan 21
Free writing prospectus
9:46pm
FWP
2sad 32t2
19 Jan 21
Free writing prospectus
5:01pm
424B5
x4u1o
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
2mvep36mbhb7jsf8a2
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
pdo9wn
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
g0fe74na
16 Dec 20
Current report (foreign)
8:00am